Aplus Biotechnology Corporation Limited (6918.TWO)

TWD 81.0

(-3.57%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 675.04 Million 615.47 Million 541.85 Million 503.28 Million -
Cost of Revenue 214.37 Million 243.94 Million 195.46 Million 185.36 Million -
Gross Profit 460.67 Million 371.53 Million 346.38 Million 317.92 Million -
Operating Expenses 292.96 Million 304.93 Million 300.24 Million 283.08 Million 41.75 Million
Selling, General and Administrative Expenses 233.43 Million 227.92 Million 237.15 Million 203.12 Million -
Research and Development Expenses 59.53 Million 77 Million 63.08 Million 79.95 Million -
Other Expenses - 2.95 Million 1.09 Million 4.35 Million 41.75 Million
Cost and Expenses 507.34 Million 548.87 Million 495.7 Million 468.44 Million 41.75 Million
Operating Income - 70.39 Million 47.66 Million 42.52 Million 41.75 Million
Interest Expense 2.7 Million 2.65 Million 2.19 Million 1.18 Million 2.07 Million
Income Tax Expense 14.34 Million 22.4 Million 10.42 Million 8.7 Million -
Earnings before Tax 45.5 Million 68.11 Million 46.05 Million 47.74 Million -
Net Income 31.15 Million 45.7 Million 32.94 Million 36.06 Million -
Earnings Per Share Basic 1.02 1.50 1.15 1.26 1.13
Earnings Per Share Diluted 1.03 1.50 1.14 1.26 1.13
Weighted Average Shares Outstanding 30.47 Million 30.47 Million 28.73 Million 28.62 Million 27.63 Million
Weighted Average Shares Outstanding (Diluted) 30.3 Million 30.54 Million 28.8 Million 28.62 Million 27.67 Million
Gross Margin 0.68 0.60 0.64 0.63 -
EBIT Margin 0.11 0.15 0.13 0.13 -
Profit Margin 0.05 0.07 0.06 0.07 -
EBITDA 74.58 Million 95.63 Million 69.68 Million 66.72 Million 67.31 Million
Earnings Before Tax Margin - 0.11 0.09 0.08 -

Income Statement Charts